Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression on palbociclib-based therapy.

Epidaza (chidamide) - Chipscreen

paclitaxel - Generic mfg.

doxorubicin hydrochloride - Generic mfg.

Ibrance (palbociclib) - Pfizer

letrozole - Generic mfg.

cyclophosphamide - Generic mfg.

Verzenio (abemaciclib) - Eli Lilly

fulvestrant - Generic mfg.

zoledronic acid - Generic mfg.

exemestane - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42210941

Weiqin Chang; Xuejiao Peng

May 30, 2026